MDT - Medtronic plc

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
30/04/2020
Total revenue
30,771,000
31,227,000
31,686,000
30,117,000
28,913,000
Cost of revenue
10,331,000
10,719,000
10,145,000
10,483,000
9,424,000
Gross profit
20,440,000
20,508,000
21,541,000
19,634,000
19,489,000
Operating expenses
Research development
2,707,000
2,696,000
2,746,000
2,493,000
2,331,000
Selling general and administrative
10,368,000
10,415,000
10,292,000
10,148,000
10,109,000
Total operating expenses
14,741,000
14,678,000
15,633,000
14,739,000
14,267,000
Operating income or loss
5,699,000
5,830,000
5,908,000
4,895,000
5,222,000
Interest expense
592,000
636,000
553,000
925,000
1,092,000
Total other income/expenses net
307,000
170,000
163,000
-75,000
-75,000
Income before tax
5,415,000
5,364,000
5,517,000
3,895,000
4,055,000
Income tax expense
1,328,000
1,580,000
456,000
265,000
-751,000
Income from continuing operations
4,087,000
3,784,000
5,062,000
3,630,000
4,806,000
Net income
4,064,000
3,758,000
5,039,000
3,606,000
4,789,000
Net income available to common shareholders
4,064,000
3,758,000
5,039,000
3,606,000
4,789,000
Basic EPS
-
-
3.75
2.68
3.57
Diluted EPS
-
-
3.73
2.66
3.54
Basic average shares
-
-
1,342,400
1,344,900
1,340,700
Diluted average shares
-
-
1,351,400
1,354,000
1,351,100
EBITDA
-
8,697,000
8,777,000
7,522,000
7,810,000